Inactive Wnt/β-catenin pathway in conventional high-grade osteosarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inactive Wnt/β-catenin pathway in conventional high-grade osteosarcoma

Published:2009-09-24 Issue:1 Volume:220 Page:24-33
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Cai Yongping,Mohseny Alexander B,Karperien Marcel,Hogendoorn Pancras CW,Zhou Gengyin,Cleton-Jansen Anne-Marie

Funder

European Commission

China Council Scholarship

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/path.2628/fullpdf

Reference54 articles.

1. Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup;Lewis;J Natl Cancer Inst,2007

2. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival-a report from the Children's Oncology Group;Meyers;J Clin Oncol,2008

3. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols;Bielack;J Clin Oncol,2002

4. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program;Mirabello;Cancer,2009

5. The Wnt signaling pathway in development and disease;Logan;Annu Rev Cell Dev Biol,2004

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of XD23 as a potent inhibitor of osteosarcoma via downregulation of DKK1 and activation of the WNT/β-catenin pathway;iScience;2024-09

2. Polyaptamer-Driven Crystallization of Alendronate for Synergistic Osteoporosis Treatment through Osteoclastic Inhibition and Osteogenic Promotion;ACS Nano;2024-08-05

3. Targeting WNT5B and WNT10B in osteosarcoma;Oncotarget;2024-08-02

4. Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy;Journal of Hematology & Oncology;2024-06-18

5. Establishment of a prognostic risk model for osteosarcoma and mechanistic investigation;Frontiers in Pharmacology;2024-04-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3